The focus of the “2014 AHA/ACC Guideline for the Management of Patients With Valvular
Heart Disease” 9, 10 (2014 VHD guideline) was the diagnosis and management of adult …

Valvular heart disease is a major cause of morbidity and mortality worldwide. Surgical valve
repair or replacement has been the standard of care for patients with valvular heart disease …

Transcatheter aortic valve replacement (TAVR) has become a well-accepted option for
treating patients with aortic stenosis at intermediate to high or prohibitive surgical risk. TAVR …

Summary Background The Placement of Aortic Transcatheter Valves (PARTNER) trial
showed that mortality at 1 year, 2 years, and 3 years is much the same with transcatheter …

The recommendations listed in this document are, whenever possible, evidence based. An
extensive review was conducted on literature published through November 2012, and other …

Background: Transcatheter aortic valve replacement (TAVR) is standard therapy for patients
with severe aortic stenosis who are at high surgical risk. However, national data regarding …

In recent times, there has been a considerable increase in the use of aortic bioprostheses
(vs. mechanical prostheses) for treating aortic valve disease, and this tendency is likely to …

The indications for catheter-based structural and electrophysiological procedures have
recently expanded to more complex scenarios, in which an accurate definition of the …

Background—We assessed trends in the performance of transcatheter aortic valve
implantation in the United Kingdom from the first case in 2007 to the end of 2012. We …

Background: Scarce data exist on the incidence of and factors associated with valve
hemodynamic deterioration (VHD) after transcatheter aortic valve replacement (TAVR) …